COVID-19 and ARCH Venture Partners

Selected Headlines

Date Headline (link) Source Relevant Snippet
11/23/2020 Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19 Menu and widgets Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19 Resilience , a new biopharmaceutical company backed by $800 million in financing from investors including ARCH Venture Partners and 8VC, has emerged from stealth to transform the way that drugs and therapies are manufactured in the U.S.Founded by ARCH Venture Partners investor Robert Nelsen, National Resilience Inc., which does business as Resilience was ...
11/23/2020 Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19 TechCrunch Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19 Resilience , a new biopharmaceutical company backed by $800 million in financing from investors including ARCH Venture Partners and 8VC, has emerged from stealth to transform the way that drugs and therapies are manufactured in the U.S.Founded by ARCH Venture Partners investor Robert Nelsen, National Resilience Inc., which does business as Resilience was born out ...
11/23/2020 Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19 ... ARCH Venture Partners and 8VC, has emerged from stealth to transform the way that drugs and therapies are manufactured in the U.S.Founded by ARCH Venture Partners investor Robert Nelsen, National Resilience Inc., which does business as Resilience was born out of Nelsen‚Aos frustrations with the inept American response to the COVID-19 pandemic.According to a statement the company will invest heavily in developing new manufacturing technologies across ...
11/23/2020 Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19 ... ARCH Venture Partners and 8VC, has emerged from stealth to transform the way that drugs and therapies are manufactured in the U.S.Founded by ARCH Venture Partners investor Robert Nelsen, National Resilience Inc., which does business as Resilience was born out of Nelsen‚Aos frustrations with the inept American response to the COVID-19 pandemic.According to a statement the company will invest heavily in developing new manufacturing technologies across ...
9/9/2020 Synthetic Biology Startups Raised $3.0 Billion In The First Half Of 2020 Forbes While Covid-19 slowed the startup economy in the first half of 2020, the bioeconomy continued to power ahead. Fifty-six synthetic biology companies pulled in just over $3 billion of equity investment in the ... identified through discussions with its initial backers, including Flagship Pioneering, ARCH Venture Partners, and F-Prime Capital. Sana Biotechnology designs cells to treat cancer, central nervous system diseases, heart disease, and genetic disorders. These specialized ...
7/22/2020 Here's how Covid-19 has affected funding, development in infectious diseases - MedCity News MedCity News ... Covid-19, drugmakers appear to have made a volte face when it comes to their interest in infectious diseases. “Everybody’s an infectious disease company now,” said Bob Nelsen, co-founder of ARCH Venture Partners, in a phone interview. “Pharmas are falling all over themselves to get into infectious diseases.” The amount of clinical activity in Covid-19 illustrates how important it has become to many companies. A search on ClinicalTrials.gov ...
7/2/2020 Digital health investments stay the course in Q2 2020 MobiHealthNews Despite the uncertainty of COVID-19, funding deals during the last three months were generally on par with those of Q1 2020 and Q2 2019. 03:16 pm Share As the broader economy ping pongs between ... BlackRock, Casdin Capital, HOF Capital, WuXi AppTec's Corporate Venture Fund, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, and Alexandria Venture Investments The funds will support the continued construction of its ...